Literature DB >> 35082944

Calciphylaxis After Aortic Valve Replacement in a Patient with End-Stage Renal Disease.

Kazunobu Hirooka1, Keisuke Anju2, Yoshihiro Moriyama2, Yuichi Araki3, Ekapot Bhunchet4, Ryoji Kinoshita1, Yohei Yamamoto1, Hidetoshi Uchiyama1, Masahiro Oonuki1, Hiroyuki Tanaka1.   

Abstract

In this study, we report a case of a patient on dialysis who presented necrotic lesions on the legs and penile ulceration 7 years after a mechanical aortic valve replacement. The diagnosis of calciphylaxis was not confirmed even after skin biopsy, and multidisciplinary management was not initiated until the patient was admitted with septic shock. Cardiovascular surgeons should be aware of warfarin-induced calciphylaxis, whose pathophysiology differs from that of atherosclerosis. Considering poor long-term survival of dialysis patients, mechanical valves should be reserved only for those patients whose estimated survival is longer than the time taken for a biological valve to deteriorate.
© 2021 The Editorial Committee of Annals of Vascular Diseases.

Entities:  

Keywords:  aortic valve replacement; calciphylaxis; end-stage renal disease

Year:  2021        PMID: 35082944      PMCID: PMC8752931          DOI: 10.3400/avd.cr.21-00040

Source DB:  PubMed          Journal:  Ann Vasc Dis        ISSN: 1881-641X


  9 in total

1.  Calcific uraemic arteriolopathy (calciphylaxis): data from a large nationwide registry.

Authors:  Vincent M Brandenburg; Rafael Kramann; Hansjörg Rothe; Nadine Kaesler; Joanna Korbiel; Paula Specht; Sophia Schmitz; Thilo Krüger; Jürgen Floege; Markus Ketteler
Journal:  Nephrol Dial Transplant       Date:  2017-01-01       Impact factor: 5.992

Review 2.  Calciphylaxis: risk factors, diagnosis, and treatment.

Authors:  Sagar U Nigwekar; Daniela Kroshinsky; Rosalynn M Nazarian; Jeremy Goverman; Rajeev Malhotra; Vicki Ann Jackson; Mihir M Kamdar; David J R Steele; Ravi I Thadhani
Journal:  Am J Kidney Dis       Date:  2015-05-07       Impact factor: 8.860

3.  Risk factors and mortality associated with calciphylaxis in end-stage renal disease.

Authors:  A R Mazhar; R J Johnson; D Gillen; J C Stivelman; M J Ryan; C L Davis; C O Stehman-Breen
Journal:  Kidney Int       Date:  2001-07       Impact factor: 10.612

4.  Cardiac valve replacement in patients on dialysis: influence of prosthesis on survival.

Authors:  R J Kaplon; D M Cosgrove; A M Gillinov; B W Lytle; E H Blackstone; N G Smedira
Journal:  Ann Thorac Surg       Date:  2000-08       Impact factor: 4.330

5.  Valve replacement in patients on chronic renal dialysis: implications for valve prosthesis selection.

Authors:  William T Brinkman; Willis H Williams; Robert A Guyton; Ellis L Jones; Joseph M Craver
Journal:  Ann Thorac Surg       Date:  2002-07       Impact factor: 4.330

6.  A 20-year multicenter analysis of dialysis-dependent patients who had aortic or mitral valve replacement: Implications for valve selection.

Authors:  Joshua L Manghelli; Daniel I Carter; Ali J Khiabani; Jason M Gauthier; Marc R Moon; Nabil A Munfakh; Ralph J Damiano; Joel S Corvera; Spencer J Melby
Journal:  J Thorac Cardiovasc Surg       Date:  2018-12-13       Impact factor: 5.209

Review 7.  Calciphylaxis: Approach to Diagnosis and Management.

Authors:  Harish Seethapathy; Lama Noureddine
Journal:  Adv Chronic Kidney Dis       Date:  2019-11       Impact factor: 3.620

8.  Clinical Assessment of Warfarin Therapy in Patients with Maintenance Dialysis-Clinical Efficacy, Risks and Development of Calciphylaxis.

Authors:  Hajime Hasegawa
Journal:  Ann Vasc Dis       Date:  2017-09-25

9.  Multi-intervention management of calcific uremic arteriolopathy in 24 patients.

Authors:  Claire Harris; Mercedeh Kiaii; Wynnie Lau; Myriam Farah
Journal:  Clin Kidney J       Date:  2018-03-09
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.